Ads
related to: cushing
Search results
Corcept (CORT) Posts Positive Data From Cushing's Syndrome Study
Zacks via Yahoo Finance· 2 days agoCorcept (CORT) reports positive data from the open-label portion of the phase III GRACE study...
Corcept falls after phase 3 results on Cushing's candidate doesn't include some data
Seeking Alpha· 3 days agoCorcept Therapeutics (CORT) reports positive phase 3 trial results for Cushing's syndrome candidate,...
I Blamed WFH For My Weight Changes and Mood. Then, I Was Diagnosed With Cushing Disease.
PopSugar· 1 day ago...sister-in-law at our Thanksgiving celebration, I noticed a lump on the back of my neck, which I...
Subtle change to skin could be an early indicator of 'silent killer' condition
Daily Express· 7 days agoDiabetes is a serious and typically lifelong condition which causes your blood sugar levels to...
'Keep pushing for answers': Maine woman shares Cushing's disease journey
WCSH 6 Portland· 2 days agoIt's a hormone disorder that affects only about 10-15 million people across the country every year. ...
Perrigo agrees to sell rare disease unit to Esteve for €275 million By Investing.com
Investing.com· 7 hours agoPerrigo Company plc (NYSE:PRGO), a global player in consumer self-care products, has entered into a...
New T2D Guidelines; More Cushing's Relacorilant Data; Drug Shortages Rage On
MedPage Today· 3 days agoThe American College of Physicians released a new guideline for the pharmacological treatment of type 2 diabetes in adults, strongly recommending the addition of an SGLT2 inhibitor, GLP-1 receptor ...
5 Signs Your Cortisol Levels Are Too High
Vogue· 14 hours agoInternet searches for cortisol were spiking last week, with Google reporting that “how to reduce cortisol” was the fourth most popular search in last 90...
Mid-Cap Corcept Therapeutics Reveals Data From Hormonal Disorder Study, FDA Application Submission...
Benzinga· 3 days agoPatients who exhibited pre-specified improvements in either or both symptoms could enter the trial’s...
Corcept Therapeutics (NASDAQ:CORT) Stock Rating Lowered by StockNews.com
ETF DAILY NEWS· 7 days agoTruist Financial upped their price objective on Corcept Therapeutics from $36.00 to $42.00 and gave the company a “buy” rating in a research note on Friday, February 16th. HC Wainwright lowered ...